William D. Waddill, Director at Protagonist Therapeutics, Inc (PTGX), sold 4,000 shares at $54.25 ($217K) on 2025-03-17, disclosed to the SEC on 2025-03-19.
Scheduled sale ($217k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PTGX | SELL | 2026-06-01 | $897K | — | Filing → |
| PTGX | SELL | 2026-02-06 | $1.7M | — | Filing → |
| ARWR | SELL | 2025-12-23 | $1.1M | — | Filing → |